The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
Abstract
The plasma membranes of hamster, mouse, and human tumor cell lines that display multiple resistance to drugs were examined by gel electrophoresis and immunoblotting. In every case, increased expression of a 170,000-dalton surface antigen was found to be correlated with multidrug resistance. This membrane component is of identical molecular size and shares some immunogenic homology with the previously characterized P-glycoprotein of colchicine-resistant Chinese hamster ovary cells. This finding may have application to cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Self-citationA highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels
Switzer, R. C., Merril, C. R., & Shifrin, S. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90732-2 · Cited by 1,085
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Self-citationMolecular Actions and Targets for Cancer Chemotherapeutic Agents
Sartorelli, A. C., Lazo, J. S., & Bertino, J. R. (1981) · Medical Entomology and Zoology · Cited by 360
Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivity
Bech‐Hansen, N. T., Till, J. E., & Ling, V. (1976) · Journal of Cellular Physiology · doi:10.1002/jcp.1040880104 · Cited by 309
Self-citationDNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.
Debenham, P. G., Kartner, N., Siminovitch, L., Riordan, J. R., & Ling, V (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.8.881 · Cited by 201
Self-citationKartner, N., Shales, M., Riordan, J. R., & Ling, V. W. T. (1983) · PubMed · Cited by 199
Self-citationHoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells.
Lalande, M., Ling, V. W. T., & Miller, R. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.363 · Cited by 148
Self-citationDRUG RESISTANCE AND MEMBRANE ALTERATION IN MUTANTS OF MAMMALIAN CELLS
Ling, V. W. T. (1975) · Canadian Journal of Genetics and Cytology · doi:10.1139/g75-064 · Cited by 128
Self-citationBrown, P. C., Beverley, S. M., & SCHIMKE, R. T. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.12.1077 · Cited by 125
Cited by
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Galati, G., & O'Brien, P. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.034 · Cited by 1,099
Ueda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3004 · Cited by 1,063
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
Kartner, N., Evernden-Porelle, D., Bradley, G., & Ling, V. (1985) · Nature · doi:10.1038/316820a0 · Cited by 908
Self-citationAmplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Self-citationIsolation and expression of a complementary DNA that confers multidrug resistance
Gros, P., Neriah, Y. B., Croop, J. M., & Housman, D. E. (1986) · Nature · doi:10.1038/323728a0 · Cited by 797
Multiple-Drug Resistance in Human Cancer
Flier, J. S., Underhill, L. H., Pastan, I., & Gottesman, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162207 · Cited by 692
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
Gerlach, J. H., Endicott, J. A., Juranka, P. F., Henderson, G., Sarangi, F., Deuchars, K. L., & Ling, V. (1986) · Nature · doi:10.1038/324485a0 · Cited by 667
Self-citationSarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., & Scarborough, G. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42909-2 · Cited by 632
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Self-citationHuman Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene Amplification
Shen, D.-W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., & Gottesman, M. M. (1986) · Science · doi:10.1126/science.3457471 · Cited by 603
Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy
ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591
Dumontet, C., & Sikic, B. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1061 · Cited by 574
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
Self-citationHamada, H., & Tsuruo, T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7785 · Cited by 546
Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
Akiyama, S.-I., Fojo, A., Hanover, J. A., Pastan, I., & Gottesman, M. M. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534700 · Cited by 529
Circumventing cancer drug resistance in the era of personalized medicine
Garraway, L. A., & Jänne, P. A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0012 · Cited by 503
Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems
Martinez, J. L., Sánchez, M. B., Martínez-Solano, L., Hernandez, A., Garmendia, L., Fajardo, A., & Alvarez-Ortega, C. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00157.x · Cited by 491
Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D., & Fiere, D. (1992) · Blood · doi:10.1182/blood.v79.2.473.473 · Cited by 487
ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
Horio, M., Gottesman, M. M., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3580 · Cited by 476
Shen, D. W., Cardarelli, C., Hwang, J., Cornwell, M., Richert, N., Ishii, S., Pastan, I., & Gottesman, M. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57466-x · Cited by 461
Robey, R. W., To, K. K. K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., & Bates, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.003 · Cited by 449
Matsuo, H., Takada, T., Ichida, K., Nakamura, T., Nakayama, A., Ikebuchi, Y., Ito, K., Kusanagi, Y., Chiba, T., Tadokoro, S., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000237 · Cited by 437
Choi, K., Chen, C.-J., Kriegler, M., & Roninson, I. B. (1988) · Cell · doi:10.1016/0092-8674(88)90568-5 · Cited by 423
Communication between Multiple Drug Binding Sites on P-glycoprotein
Martin, C., Berridge, G., Higgins, C. F., Mistry, P., Charlton, P., & Callaghan, R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12429-7 · Cited by 418
Critical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein
Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V., & Riordan, J. R. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80136-x · Cited by 411
Self-citationGenetic and biochemical characterization of multidrug resistance
Riordan, J. R., & Ling, V. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90082-8 · Cited by 398
Self-citationMarie, J., Zittoun, R., & Sikic, B. (1991) · Blood · doi:10.1182/blood.v78.3.586.586 · Cited by 394
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
Georges, E., Bradley, G., Gariepy, J., & Ling, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.152 · Cited by 384
Self-citationModulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Cornwell, M. M., Safa, A. R., Felsted, R. L., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3847 · Cited by 338
Hamada, H., & Tsuruo, T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57324-0 · Cited by 332
Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N., & Varshavsky, A. (1984) · Nature · doi:10.1038/309626a0 · Cited by 332
P-Glycoproteins and Multidrug Resistance
Bellamy, W. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001113 · Cited by 319
Zhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols
Jodoin, J., Demeule, M., & Béliveau, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00175-6 · Cited by 300
ABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 298
Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance
Kramer, R. A., Zakher, J., & Kim, G. (1988) · Science · doi:10.1126/science.3399900 · Cited by 295
Hunter, J., & Hirst, B. H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00497-3 · Cited by 291
Sequence of mdr3 cDNA encoding a human P-glycoprotein
van der Bliek, A. M., Kooiman, P. M., Schneider, C., & Borst, P. (1988) · Gene · doi:10.1016/0378-1119(88)90057-1 · Cited by 289
Hebert, M. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00043-4 · Cited by 288
Safa, A. R., Glover, C. J., Meyers, M. B., Biedler, J. L., & Felsted, R. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84537-4 · Cited by 287
The Multixenobiotic Resistance Mechanism in Aquatic Organisms
Kurelec, B. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145320 · Cited by 287
Ueda, K., Pastan, I., & Gottesman, M. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45397-5 · Cited by 286
Marchetti, S., Mazzanti, R., Beijnen, J. H., & Schellens, J. H. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-927 · Cited by 284
Van der Bliek, A. M., Baas, F., Ten Houte de Lange, T., Kooiman, P. M., Van der Velde-Koerts, T., & Borst, P. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02653.x · Cited by 281
The multidrug resistance gene PDR1 from Saccharomyces cerevisiae.
Balzi, E., Chen, W., Ulaszewski, S., Capieaux, E., & Goffeau, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45464-6 · Cited by 276
Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
Kovtun, Y. V., Audette, C. A., Mayo, M. F., Jones, G. E., Doherty, H., Maloney, E. K., Erickson, H. K., Sun, X., Wilhelm, S., Ab, O., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3546 · Cited by 266
Arceci, R. J., Croop, J. M., Horwitz, S. B., & Housman, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4350 · Cited by 265
Metal complexes as diagnostic tools
Reichert, D. E., Lewis, J. S., & Anderson, C. J. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00207-0 · Cited by 263
Van der Bliek, A. M., Van der Velde-Koerts, T., Ling, V, & Borst, P. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1671 · Cited by 258
Self-citationThe molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein
Martin, C., Berridge, G., Mistry, P., Higgins, C., Charlton, P., & Callaghan, R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702807 · Cited by 258
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
Liang, X.-J., Meng, H., Wang, Y., He, H., Meng, J., Lu, J., Wang, P. C., Zhao, Y., Gao, X., Sun, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909707107 · Cited by 256
P-glycoprotein in human sarcoma: evidence for multidrug resistance.
Gerlach, J. H., Bell, D. R., Karakousis, C., Slocum, H. K., Kartner, N., Rustum, Y. M., Ling, V, & Baker, R. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1452 · Cited by 255
Self-citationRegulation of protein kinase C and role in cancer biology
Blobe, G. C., Obeid, L. M., & Hannun, Y. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666107 · Cited by 255
Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.
Cornwell, M. M., Gottesman, M. M., & Pastan, I. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57491-9 · Cited by 253
The Roles of MicroRNAs in Breast Cancer
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2015) · Cancers · doi:10.3390/cancers7020598 · Cited by 116
Duesberg, P., Stindl, R., & Hehlmann, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201398998 · Cited by 106
Metadata
- Authors
- Kartner, N., Riordan, J. R., & Ling, V.
- Venue
- Science
- Published
- 1983-09-23
- Volume
- 221
- Issue
- 4617
- Pages
- 1285-1288
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1997241897
- Cited by
- 991
- References
- 15
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.